RETRACTED: Protective effects of ghrelin on cisplatin-induced nephrotoxicity in mice.
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).

This article has been retracted at the request of the Authors.

The Authors express that: although main outcome is correct, there are some errors in calculation, statistical analysis, description for sample numbers and data preparation including, using the common control and vehicle group already reported in the other paper. Those experiments were performed at the same time but, we lacked explanation for those condition (Cancer Chemother Pharmacol. 2015;75:123-9). Taken together, we decided to retract this article due to those errors.
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan. Electronic address: nojiri@ri.ncvc.go.jp.
Takashi
T
Nojiri
Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center, Suita-City, Osaka, Japan.
Hiroshi
H
Hosoda
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan.
Toru
T
Kimura
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan.
Takeshi
T
Tokudome
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan.
Koichi
K
Miura
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan.
Hiroyuki
H
Takabatake
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan.
Mikiya
M
Miyazato
Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Suita-City, Osaka, Japan.
Meinoshin
M
Okumura
Department of Biochemistry, National Cerebral and Cardiovascular Center Research Institute, Suita-City, Osaka, Japan.
Kenji
K
Kangawa
D058186:Acute Kidney Injury / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001806:Blood Urea Nitrogen; D018932:Chemokine CCL2 / Q000235:genetics; D002945:Cisplatin / Q000009:adverse effects; D005786:Gene Expression Regulation; D054439:Ghrelin / Q000008:administration & dosage*; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D018932:Chemokine CCL2; D054439:Ghrelin; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D002945:Cisplatin
Cisplatin; Ghrelin; Inflammation; Nephrotoxicity